CDC25A and breast cancer: Again, Wang et al. demonstrated that introducing FoxM1 siRNA resulted in reduction in both protein and mRNA level of AURKA and M-phase inducer phosphatase 1 (CDC25A), thus reinforcing the hypothesis that AURKA might be a direct transcriptional target of FoxM1 in breast cancer cell lines [36].